KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Assets (2016 - 2025)

Regeneron Pharmaceuticals (REGN) has 14 years of Return on Assets data on record, last reported at 0.12% in Q3 2025.

  • For Q3 2025, Return on Assets changed N/A year-over-year to 0.12%; the TTM value through Sep 2025 reached 0.12%, changed N/A, while the annual FY2024 figure was 0.12%, 0.0% changed from the prior year.
  • Return on Assets reached 0.12% in Q3 2025 per REGN's latest filing, down from 0.12% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.18% in Q3 2022 and bottomed at 0.04% in Q3 2023.
  • Average Return on Assets over 4 years is 0.1%, with a median of 0.12% recorded in 2024.
  • The widest YoY moves for Return on Assets: up 6bps in 2023, down -14bps in 2023.
  • A 4-year view of Return on Assets shows it stood at 0.06% in 2022, then surged by 111bps to 0.12% in 2023, then decreased by -3bps to 0.12% in 2024, then decreased by 0bps to 0.12% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.12% in Q3 2025, 0.12% in Q2 2025, and 0.12% in Q1 2025.